Press Release

 

Velocity Mobile is delighted to announce the launch of a tailored Mobile CRM application (“PVTS”) for Merck Serono enabling patient visit tracking in Hong Kong. Merck Serono is a global biopharmaceutical company, and the largest business arm of the Merck Group.

 

The  deployment of PVTS this month supports the long-standing commitment of Merck Serono to improving the lives of people living with multiple sclerosis.

“PVTS will significantly streamline the process of monitoring patient treatment for Merck Serono nurses and administrative staff with a mobile solution that provides real time patient information during home visits.” explained Leslie Liu, IT Manager, Group Information Services, Merck HK.

 

In addition to effectively managing & monitoring MS patients at each critical stage in the treatment life cycle, the mobile application for tablets and smartphones has a comprehensive set of analytics to support the ongoing improvement of established treatments with multiple sclerosis patients.

 

“Velocity Mobile has appreciated the opportunity to collaborate closely with the Merck HK business and technical teams in building an innovative mobile solution that will ultimately lead to improvement in the lives of Hong Kong’s MS sufferers through more effective E2E treatment management.” said Peter Smith, Managing Director of Velocity Mobile.

 

Velocity Mobile looks forward to continuing its partnership with Merck Serono in building effective high tech solutions for the Hong Kong health care industry. 

 

 

About Velocity Mobile:

 

Velocity Mobile is a specialist mobile solution provider that builds business applications for the global market.  We develop integrated, end-to-end business solutions that connect you with your customers.

With offices in Hong Kong, Brisbane, Vancouver and Manila, our experienced team supports local, regional and multinational customers globally. Velocity Mobile has a highly skilled management and technical team with a deep understanding of corporate and business environments.

 

 

About Merck Serono:

 

Merck Serono is the biopharmaceutical business of Merck. With headquarters in Darmstadt, Germany, Merck Serono offers leading brands in 150 countries to help patients with cancer, multiple sclerosis, infertility, endocrine and metabolic disorders as well as cardiovascular diseases.

 

Merck Serono discovers, develops, manufactures and markets prescription medicines of both chemical and biological origin in specialist indications. We have an enduring commitment to deliver novel therapies in our core focus areas of neurology, oncology, immuno-oncology and immunology.

 

 

For further media enquiries, please contact:

 

​Peter Smith

 

Managing Director velocity>mobile

 

Direct: +852 9199 4880

 

Email: peter.smith@velocity-mobile.com